Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma

Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma

Bibliographic Details
Main Authors:	M Tinguely, S Vallet, B Jenni, M Witzens-Harig, G Mechtersheimer, AD Ho, H Goldschmidt, D Jäger, M Boccadoro, M Ladetto
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2006-07-01
Series:	Swiss Medical Weekly
Subjects:	Prognosis COX2 inhibitor immunohistochemistry Cyclooxygenase 2 inhibitor multiple myeloma
Online Access:	https://www.smw.ch/index.php/smw/article/view/617

Similar Items

Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature
by: Alessandra Pannunzio, et al.
Published: (2018-10-01)

Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion
by: T Kistler, et al.
Published: (2001-04-01)

COX-2 in Cancer: Gordian knot or Achilles heel?
by: Ioannis eStasinopoulos, et al.
Published: (2013-03-01)

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years
by: Zhiran Ju, et al.
Published: (2022-06-01)

Different expression of cyclooxygenase-2 (COX-2) in selected nonmelanocytic human cutaneous lesions
by: Barbara W. Chwirot, et al.
Published: (2011-10-01)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
by: Chitra Rawat, et al.
Published: (2019-10-01)

Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines
by: Francesca Lombardi, et al.
Published: (2022-01-01)

Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors
by: U Klotz
Published: (2005-03-01)

A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy
by: Monika Berbecka, et al.
Published: (2021-09-01)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012-10-01)

COX-2 selective inhibitors - they are still the best treatment for many patients!
by: K Brune
Published: (2005-03-01)

The Influence of Glycosylation of Natural and Synthetic Prenylated Flavonoids on Binding to Human Serum Albumin and Inhibition of Cyclooxygenases COX-1 and COX-2
by: Tomasz Tronina, et al.
Published: (2017-07-01)

A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets
by: Qianghua Hu, et al.
Published: (2017-01-01)

Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features
by: Sandhya VENKATACHALA, et al.
Published: (2017-09-01)

The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation
by: W. E. Longo, et al.
Published: (1998-01-01)

Hippocampal Over-Expression of Cyclooxygenase-2 (COX-2) Is Associated with Susceptibility to Stress-Induced Anhedonia in Mice
by: Tatyana Strekalova, et al.
Published: (2022-02-01)

Limited Proteolysis of Cyclooxygenase-2 Enhances Cell Proliferation
by: Esraa Saadi, et al.
Published: (2020-04-01)

COX-2 as a potential biomarker and therapeutic target in melanoma
by: Diana Valentina Tudor, et al.
Published: (2020-02-01)

Molecular docking study of active phytocompounds from the methanolic leaf extract of vitex negundo against cyclooxygenase-2
by: Deepa Murugesan, et al.
Published: (2014-03-01)

Biology of cyclooxygenase-2: An application in depression therapeutics
by: Ying He, et al.
Published: (2022-11-01)

Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors
by: Deema A. Al-Turki, et al.
Published: (2017-01-01)

Single bolus parecoxib attenuates sore throat after laryngeal microsurgery: A randomized double-blind control study
by: Hui-Fang Huang, et al.
Published: (2014-11-01)

Cyclooxygenase-2 identified as a potential target for novel radiomodulator scopolamine methyl bromide: An in silico study
by: Nitisha Shrivastava, et al.
Published: (2017-01-01)

Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells
by: Kaipeng Jin, et al.
Published: (2023-01-01)

NSAIDs and Cell Proliferation in Colorectal Cancer
by: Raj Ettarh, et al.
Published: (2010-06-01)

Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects
by: Yang L, et al.
Published: (2022-11-01)

COX-2 inhibitors /
by: Pairet, M. (Michel), 1959-, et al.
Published: (2004)

COMPUTATION DESIGN OF QUINAZOLINE-4(3H)-ON DERIVATIVES AS CYCLOOXYGENASE-2 (COX-2) INHIBITOR
by: Anita Puspa Widiyana
Published: (2021-11-01)

Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders
by: Maria Grazia Perrone, et al.
Published: (2020-11-01)

Evaluation of curcumin derivatives as new cyclooxygenase-2 inhibitors via in silico and in vitro analyses
by: Abdul Bahari, Mohammad Nazri
Published: (2016)

2-Butyl-6-phenyl-4,5-dihydropyridazin-3(2<em>H</em>)-one: Synthesis, In Silico Studies and In Vitro Cyclooxygenase-2 Inhibitory Activity
by: Mohd Imran
Published: (2020-08-01)

The Effect of Selectivity of Inhibitors to Cox-2 Enzyme on Hepatobiliary and Platelet Function in Patients with Osteoarthritis
by: Ali M. Hadi, et al.
Published: (2010-01-01)

OPTIMIZING STRUCTURE-BASED VIRTUAL SCREENING PROTOCOL TO IDENTIFY PHYTOCHEMICALS AS CYCLOOXYGENASE-2 INHIBITORS
by: Enade Perdana Istyastono
Published: (2016-07-01)

Chromatographic techniques in analysis of cyclooxygenase-2 inhibitors in drugs and biological samples
by: Starek Małgorzata, et al.
Published: (2012-06-01)

Expression of cyclooxygenase-1 and 2 in chronic tonsillitis
by: Dilek Fatma, et al.
Published: (2010-07-01)

Cyclooxygenase-2 (COX-2) Expression in Equine Melanocytic Tumors
by: José Pimenta, et al.
Published: (2024-02-01)

Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches
by: Pedro H. F. Araújo, et al.
Published: (2020-09-01)

Effect of Cyclooxygenase-2 Inhibitors in Double J Stent Removal under Local Anesthesia
by: Rulianov Rulianov, et al.
Published: (2021-10-01)

THE CONTENT OF VEGF, COX-2 AND PGE-2 DEPENDING ON THE OBJECTIVE RESPONSE TO RADIATION THERAPY IN COMBINATION WITH A COX-2 INHIBITOR IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
by: Н.А. Мітряєва, et al.
Published: (2020-04-01)

Flavanones from Sorghum bicolor selectively inhibit COX-2: in-silico and in-vivo validation
by: O. Adeboye Akinloye, et al.
Published: (2019-12-01)